English

TRADING UPDATE Q4-2020 FINANCIAL RESULTS

Report this content

Oslo, Norway (15 February 2021) — In connection with the voluntary offer by Lesaffre being announced this morning, NattoPharma hereby announces the following key financials for Q4 2020 and FY 2020:

Q4 2020 revenue and adj. EBITDA amounts to NOK 62.3m and NOK 14.4m, respectively (adj. EBITDA margin of 23.1%).

FY 2020 revenue and adj. EBITDA amounts to NOK 214.5m and NOK 37.3m, respectively (adj. EBITDA margin of 17.4%).

NattoPharma will release the Q4 2020 report on 17 February 2021. The presentation will be held as earlier communicated at 10:00 AM CET that same day. However, there will be no Q&A as earlier indicated.

For more information, please contact:

Robert Schrama

CFO, NattoPharma

E-mail: robert.schrama@nattopharma.com

Documents & Links